Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33

Applied Microbiology and Biotechnology

Volumn 95, Issue 5, 2012, Pages 1191-1198

  Feng, Xingjun ^a   Liu, Chunlong ^b   Guo, Jiayin ^a   Song, Xueying ^a   Li, Jing ^a   Xu, Wenshan ^a   Li, Zhongqiu ^c  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b NORTHEAST INSTITUTE OF GEOGRAPHY AND AGRICULTURAL ECOLOGY   (China)

^c HEILONGJIANG ACADEMY OF AGRICULTURAL SCIENCES   (China)

Author keywords

Antimicrobial peptides; Hybrid peptides; LfcinB; Prokaryotic expression; Thanatin

Indexed keywords

ANTIMICROBIAL PEPTIDE; HYBRID PEPTIDES; LFCINB; PROKARYOTIC EXPRESSION; THANATIN;

AFFINITY CHROMATOGRAPHY; ANTIBIOTICS; BIOSYNTHESIS; ESCHERICHIA COLI; MASS SPECTROMETRY; PEPTIDES; PURIFICATION; VIRUSES;

POLYPEPTIDES;

ANTIMICROBIAL PEPTIDE LFT33; COMPLEMENTARY DNA; DNA FRAGMENT; POLYPEPTIDE ANTIBIOTIC AGENT; THANATIN; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; HYBRID PROTEIN;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOENGINEERING; BLOOD; ENZYME ACTIVITY; GENE EXPRESSION; PEPTIDE; PROTEIN; PURIFICATION; RECOMBINATION;

AFFINITY CHROMATOGRAPHY; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BIOENGINEERING; CANDIDA ALBICANS; CODON; DRUG PURIFICATION; ENTEROBACTER AEROGENES; ERYTHROCYTE; ESCHERICHIA COLI; HEMOLYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SALMONELLA GALLINARUM; STAPHYLOCOCCUS AUREUS; BACTERIUM; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION; GENE VECTOR; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; ISOLATION AND PURIFICATION;

ESCHERICHIA COLI; PROKARYOTA;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CANDIDA ALBICANS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC VECTORS; INHIBITORY CONCENTRATION 50; MASS SPECTROMETRY; MOLECULAR WEIGHT; RECOMBINANT FUSION PROTEINS;

EID: 84870658238     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-011-3816-z     Document Type: Article

References (38)

1. Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG (1992) Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett 296(2):190-194
2. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M (1992) Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73(6):472-479
3. Bellamy W, Wakabayashi H, Takase M, Kawase K, Shimamura S, Tomita M (1993) Killing of Candida albicans by lactoferricinB, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol (Berl) 182(2):97-105
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
5. Dathe M, Wieprecht T (1999) Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes. Biochim Biophys Acta 1462(1-2):71-87
6. Diamond G, Beckloff N, Weinberg A, Kisich KO (2009) The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15(21):2377-2392
7. Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA (1996) Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci USA 93(3):1221-1225
8. Ferre R, Melo MN, Correia AD, Feliu L, Bardají E, Planas M, Castanho M (2009) Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100. Biophys J 96(5):1815-1827
9. Freiburghaus C, Janicke B, Lindmark-Månsson H, Oredsson SM, Paulsson MA (2009) Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line. J Dairy Sci 92(6):2477-2484
10. Gobbo M, Benincasa M, Bertoloni G, Biondi B, Dosselli R, Papini E, Reddi E, Rocchi R, Tavano R, Gennaro R (2009) Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation. J Med Chem 52(16):5197-5206
11. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551-1557
12. Haversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I (2002) Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol 220(2):83-95
13. Huang L, Leong SS, Jiang R (2009) Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27. Appl Microbiol Biotechnol 84(2):301-308
14. Ingham AB, Moore RJ (2007) Recombinant production of antimicrobial peptides in heterologous microbial systems. Biotechnol Appl Biochem 47(Pt 1):1-9
15. Kim JM, Jang SA, Yu BJ, Sung BH, Cho JH, Kim SC (2008) High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage. Appl Microbiol Biotechnol 78(1):123-130
16. Koo YS, Kim JM, Park IY, Yu BJ, Jang SA, Kim KS, Park CB, Cho JH, Kim SC (2008) Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide. Peptides 29(7):1102-1108
17. Lee MK, Cha L, Lee SH, Hahm KS (2002) Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. J Biochem Mol Biol 35(3):291-296
18. Li L, Wang JX, Zhao XF, Kang CJ, Liu N, Xiang JH, Li FH, Sueda S, Kondo H (2005) High level expression, purification, and characterization of the shrimp antimicrobial peptide, Ch-penaeidin, in Pichia pastoris. Protein Expr Purif 39(2):144-151
19. Maher S, McClean S (2006) Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem Pharmacol 71(9):1289-1298
20. Marr AK, Jenssen H, Moniri MR, Hancock RE, Panté N (2009) Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochimie 91(1):160-164
21. Monincová L, Budesínský M, Slaninová J, Hovorka O, Cvacka J, Voburka Z, Fucík V, Borovicková L, Bednárová L, Straka J, Cerovský V (2010) Novel antimicrobial peptides from the venom of the eusocial bee Halictus sexcinctus (Hymenoptera: Halictidae) and their analogs. Amino Acids 39(3):763-775
22. National Committee for Clinical Laboratory Standards (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6. Villanova, PA
23. Omata Y, Satake M, Maeda R, Saito A, Shimazaki K, Yamauchi K, Uzuka Y, Tanabe S, Sarashina T, Mikami T (2001) Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoite by treatment with bovine lactoferricin. J Vet Med Sci 63:187-190
24. Oo TZ, Cole N, Garthwaite L, Willcox MD, Zhu H (2010) Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection. J Antimicrob Chemother 65(6):1243-1251
25. Park Y, Lee DG, Hahm KS (2004) HP(2-9)-magainin 2(1-12), a synthetic hybrid peptide, exerts its antifungal effect on Candida albicans by damaging the plasma membrane. J Pept Sci 10(4):204-209
26. Rekdal Ø, Andersen J, Vorland LH, Svendsen JS (1999) Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity. J Pept Sci 5(1):32-45
27. Scudiero O, Galdiero S, Cantisani M, Di Noto R, Vitiello M, Galdiero M, Naclerio G, Cassiman JJ, Pedone C, Castaldo G, Salvatore F (2010) Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob Agents Chemother 54(6):2312-2322
28. Shin SY, Kang JH, Lee MK, Kim SY, Kim Y, Hahm KS (1998) Cecropin A-magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect. Biochem Mol Biol Int 44(6):1119-1126
29. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J Jr (2008) The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46(2):155-164
30. Strøm MB, Rekdal Ø, Svendsen JS (2000) Antibacterial activity of 15-residue lactoferricin derivatives. J Pept Res 56(5):265-274
31. Strøm MB, Haug BE, Rekdal Ø, Skar ML, Stensen W, Svendsen JS (2002) Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Biochem Cell Biol 80(1):65-74
32. Taguchi S, Kuwasako K, Suenaga A, Okada M, Momose H (2000) Functional mapping against Escherichia coli for the broad-spectrum antimicrobial peptide, thanatin, based on an in vivo monitoring assay system. J Biochem 128(5):745-754
33. Tian ZG, Dong TT, Teng D, Yang YL, Wang JH (2009) Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method. Appl Microbiol Biotechnol 82(6):1097-1103
34. Ulvatne H, Samuelsen Ø, Haukland HH, Krämer M, Vorland LH (2004) Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol Lett 237(2):377-384
35. Wakabayashi H, Teraguchi S, Tamura Y (2002) Increased Staphylococcus-killing activity of an antimicrobial peptide, lactoferricin B, with minocycline and monoacylglycerol. Biosci Biotechnol Biochem 66(10):2161-2167
36. Wu M, Hancock RE (1999) Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 274(1):29-35
37. Zasloff M (2002) Antimicrobial peptides of multicellular organism. Nature 414(6870):389-395
38. Zorko M, Jerala R (2010) Production of recombinant antimicrobial peptides in bacteria. Meth Mol Biol 618:61-76